LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Urine Analyzer Evaluated for Performance

By LabMedica International staff writers
Posted on 02 Oct 2017
Image: The UF-5000 fully automated urine analyzer (Photo courtesy of Sysmex Europe).
Image: The UF-5000 fully automated urine analyzer (Photo courtesy of Sysmex Europe).
Urinalysis is one of the most commonly requested laboratory tests, the third after the biochemical profile and the blood cell count, and it is very useful to screen for diseases of the kidney and urinary tract.

Microscopic evaluation of the sediment particles is a time consuming procedure, with high imprecision and inaccuracy; furthermore, it requires expert knowledge and it is strongly influenced by the inter-observer variability. In recent years, automation of urinary sediment has overcome these limits.

Clinical chemists at the Papa Giovanni XXIII Hospital (Bergamo, Italy) selected 736 fresh, first morning, clean catch mid-stream urine samples from the samples sent to the Clinical Chemistry Laboratory during the period May–October 2016. Samples were selected in order to cover all the linearity range for all the parameters where possible; analyses concentrations were distributed over the analytical measurement range of the urine analyzer.

Each sample was sequentially analyzed on the Aution Max AX-4280 automated urine test strip analyzer and the Sysmex UF-1000i. The new analyzer evaluated was the Sysmex UF-5000 which is able to recognize, count and classify cells by analyzing forward scatter light (FSC), side scatter light (SSL), side fluorescent light (SFL) and depolarized side scattered light (DSS). DSS was introduced to improve the sensitivity of crystals and to better discriminate the red blood cells and crystals. For the comparative method, Fuchs-Rosenthal chamber (FRC) counting with a phase contrast microscope using an eyepiece set at ×10and a lens set at ×40, for a total of ×400, was used as a reference manual method.

The scientists reported that the AUC of ROC curve ranged between 0.86 and 0.99. Sensitivity was greater than 90% for all the elements and similar for red blood cells (RBC) and yeasts. Specificity ranged between 74% and 89% for total cast, epithelial/non-squamous/renal-tubular cells and RBC. For all the other parameters specificity was greater than 90%. Comparison with Fuchs- Rosenthal chamber was very good for all the parameters except for pathological cast because of the lack of the pathological samples in medium and higher ranges.

The authors concluded that their study assessed the newly introduced UF-5000 which they found is a really simple, useful and accurate analyzer to detect urine particles related to the pathological process of kidney and urinary tract. All the parameters showed a high negative predictive value (NPV), so it is possible to exclude the presence of a disease with a great probability when a urine sample is negative.

On the other hand, the robust statistical analysis observed for all the parameters, especially those with an important clinical impact and higher than the ones obtained by image-based analyzers, makes UF-5000 an analyzer of great interest, recommended in routine practice, also for complex case mix laboratory. The study was published in the September 2017 issue of the journal Clinica Chimica Acta.

Related Links:
Papa Giovanni XXIII Hospital

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Automatic CLIA Analyzer
Shine i9000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more